Is there any vindication for low dose nonselective beta-blocker medication in patients with liver cirrhosis?
Clinical and Molecular Hepatology
;
: 203-212, 2012.
Article
in English
| WPRIM
| ID: wpr-101277
ABSTRACT
BACKGROUND/AIMS:
Nonselective beta-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB medication has beneficial effects in patients with liver cirrhosis, especially in terms of overall survival.METHODS:
We retrospectively studied 273 cirrhotic patients (199 males; age 53.6+/-10.2 years, mean+/-SD) who visited our institution between March 2003 and December 2007; follow-up data were collected until June 2011. Among them, 138 patients were given a low-dose NSBB (BB group propranolol, 20-60 mg/day), and the remaining 135 patients were not given an NSBB (NBB group). Both groups were stratified randomly according to Child-Turcotte-Pugh (CTP) classification and age.RESULTS:
The causes of liver cirrhosis were alcohol (n=109, 39.9%), hepatitis B virus (n=125, 45.8%), hepatitis C virus (n=20, 7.3%), and cryptogenic (n=19, 7.0%). The CTP classes were distributed as follows A, n=116, 42.5%; B, n=126, 46.2%; and C, n=31, 11.4%. Neither the overall survival (P=0.133) nor the hepatocellular carcinoma (HCC)-free survival (P=0.910) differed significantly between the BB and NBB groups [probability of overall survival at 4 years 75.1% (95% CI=67.7-82.5%) and 81.2% (95% CI=74.4-88.0%), respectively; P=0.236]. In addition, the delta CTP score did not differ significantly between the two groups.CONCLUSIONS:
Use of low-dose NSBB medication in patients with liver cirrhosis is not indicated in terms of overall and HCC-free survival.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Propranolol
/
Severity of Illness Index
/
Alcohol Drinking
/
Proportional Hazards Models
/
Predictive Value of Tests
/
Retrospective Studies
/
Follow-Up Studies
/
Carcinoma, Hepatocellular
/
Adrenergic beta-Antagonists
/
Kaplan-Meier Estimate
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
Clinical and Molecular Hepatology
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS